Rare inflammatory diseases of the white matter and mimics of multiple sclerosis and related disorders

Neuropediatrics

Volumn 44, Issue 6, 2013, Pages 302-308

  Tardieu, Marc ^a,b   Deiva, Kumaran ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

acute disseminated encephalomyelitis; inflammatory diseases; multiple sclerosis; neuroimmunology; white matter

Indexed keywords

ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; C REACTIVE PROTEIN; FERRITIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECEPTOR ANTIBODY; RITUXIMAB; TRIACYLGLYCEROL;

ACUTE BRAIN DISEASE; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ARACHNOIDITIS; ASTROCYTOMA; BASAL GANGLION; BONE MARROW BIOPSY; BRAIN BIOPSY; CADASIL; CD8+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CONSENSUS; CORPUS CALLOSUM; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENCEPHALITIS; EPILEPTIC DISCHARGE; ERYTHROCYTE SEDIMENTATION RATE; HASHIMOTO ENCEPHALOPATHY; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL PRESSURE; LARGE CELL LYMPHOMA; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; LYME DISEASE; LYMPHOBLASTOMA; LYMPHOMA; MULTIPLE SCLEROSIS; MUSCLE BIOPSY; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OPTIC NEURITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SEROLOGY; SPINAL CORD LESION; VASCULITIS; WHITE MATTER; WHITE MATTER LESION;

HUMANS; INFLAMMATION; LEUKOENCEPHALOPATHIES; MULTIPLE SCLEROSIS; RARE DISEASES;

EID: 84888324645     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0033-1358599     Document Type: Review

References (32)

1. Polman C. H., Reingold S. C., Banwell B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol: 2011; 69 2 292 302
2. Sadaka Y., Verhey L. H., Shroff M. M., et al. Canadian Pediatric Demyelinating Disease Network. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol: 2012; 72 2 211 223
3. Krupp L. B., Tardieu M., Amato M. P., et al. International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler: 2013; 19 10 1261 1267
4. Mikaeloff Y., Caridade G., Husson B., Suissa S., Tardieu M.; Neuropediatric KIDSEP Study Group of the French Neuropediatric Society. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol: 2007; 11 2 90 95
5. Neuteboom R. F., Boon M., Catsman Berrevoets C. E., et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology: 2008; 71 13 967 973
6. Pohl D., Rostasy K., Reiber H., Hanefeld F. CSF characteristics in early-onset multiple sclerosis. Neurology: 2004; 63 10 1966 1967 (Pubitemid 39532406)
7. 1H MRS - a multi-centre study. Eur J Cancer: 2013; 49 3 658 667
8. Haddad E., Sulis M. L., Jabado N., Blanche S., Fischer A., Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood: 1997; 89 3 794 800 (Pubitemid 27121272)
9. Horne A., Trottestam H., Aricò M., et al. Histiocyte Society. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol: 2008; 140 3 327 335
10. Janka G. E. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med: 2012; 63 233 246
11. Deiva K., Mahlaoui N., Beaudonnet F., et al. CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology: 2012; 78 15 1150 1156
12. Mahlaoui N., Ouachée-Chardin M., de Saint Basile G., et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics: 2007; 120 3 e622 e628 (Pubitemid 47358275)
13. Ouachée-Chardin M., Elie C., de Saint Basile G., et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics: 2006; 117 4 e743 e750 (Pubitemid 46071479)
14. Castillo P., Woodruff B., Caselli R., et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol: 2006; 63 2 197 202 (Pubitemid 43261730)
15. Mamoudjy N., Korff C., Maurey H., et al. Hashimoto's encephalopathy: identification and long-term outcome in children. Eur J Paediatr Neurol: 2013; 17 3 280 287
16. Erol I., Saygi S., Alehan F. Hashimoto's encephalopathy in children and adolescents. Pediatr Neurol: 2011; 45 6 420 422
17. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M. R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol: 2011; 10 1 63 74
18. Florance N. R., Davis R. L., Lam C., et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol: 2009; 66 1 11 18
19. Wingerchuk D. M., Lennon V. A., Pittock S. J., Lucchinetti C. F., Weinshenker B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology: 2006; 66 10 1485 1489 (Pubitemid 43958540)
20. Collongues N., Marignier R., Zéphir H., et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology: 2010; 75 12 1084 1088
21. McKeon A., Lennon V. A., Lotze T., et al. CNS aquaporin-4 autoimmunity in children. Neurology: 2008; 71 2 93 100
22. Pittock S. J., Lennon V. A., McKeon A., et al. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol: 2013; 12 6 554 562
23. Papeix C., Vidal J. S., de Seze J., et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler: 2007; 13 2 256 259 (Pubitemid 46592781)
24. Rocha R., Lisboa L., Neves J., García López M., Santos E., Ribeiro A. Neuroborreliosis presenting as acute disseminated encephalomyelitis. Pediatr Emerg Care: 2012; 28 12 1374 1376
25. O'Connell S. Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis: 2010; 23 3 231 235
26. Orphanidou-Vlachou E., Auer D., Brundler M. A., et al. (1)H magnetic resonance spectroscopy in the diagnosis of paediatric low grade brain tumours. Eur J Radiol: 2013; 82 6 e295 e301
27. Abla O., Weitzman S., Blay J. Y., et al. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Clin Cancer Res: 2011; 17 2 346 352
28. Rice G., Patrick T., Parmar R., et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet: 2007; 81 4 713 725 (Pubitemid 47596540)
29. Crow Y. J., Hayward B. E., Parmar R., et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi- Goutières syndrome at the AGS1 locus. Nat Genet: 2006; 38 8 917 920 (Pubitemid 44141660)
30. Rice G. I., Bond J., Asipu A., et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet: 2009; 41 7 829 832
31. Rademakers R., Baker M., Nicholson A. M., et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet: 2012; 44 2 200 205
32. Harding A. E., Sweeney M. G., Miller D. H., et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain: 1992; 115 Pt 4 979 989